Loading clinical trials...

Prospective Registry of EoSinophilic esOphagitis | Clinical Trials | Clareo Health

RECRUITING

Prospective Registry of EoSinophilic esOphagitis

Prospective Registry of EoSinophilic esOphagitis (PRESO)

NCT06443346•IRCCS San Raffaele

Summary

This is a prospective registry of all the Eosinophilic Esophagitis (EoE) patients referred to the third level referral centre of San Raffaele Scientific Institute

Detailed Description

Primary objective of the study is to create a registry of all EoE patients with \> 18 years of age referring to the Motility and EoE Unit of San Raffaele Hospital, in order to register clinical, endoscopic and histologic data on the disease, to further design and propose future prospective or retrospective studies to increase disease knowledge and foster collaborations with other centers nationally and internationally

Eligibility

Age

All ages

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•1. Participant is willing and able to give informed consent for participation in the study.
•2. The medical product is the standard of care for the patient or the participant is taking the medicinal product according to clinical practice
•3. Being diagnosed with EoE as per guidelines of the disease

Exclusion Criteria

•1. No clear diagnosis of EoE
•2. Not willing to provide informed consent to the inclusion in the registry

Locations (1)

IRCCS San Raffaele

Milan, Lombardy, Italy

Key Dates

Start Date

June 1, 2024

Primary Completion Date

December 31, 2034

Completion Date

December 31, 2044

Last Updated

July 30, 2025

Enrollment

1,000

ESTIMATED participants

Conditions

Eosinophilic Esophagitis

Interventions

Eosinophilic Esophagitis

OTHER

Contacts

Alberto Barchi, MD

CONTACT

3348630784 barchi.alberto@hsr.it

A U.S. Registry of Eosinophilic Esophagitis Pediatric, Adolescent and Adult Patients Treated With DUPIXENT® As Standard of Care

NCT06693531

Eosinophilic Esophagitis (EoE)

View study

RECRUITING

Eosinophilic Gastrointestinal Disorders Registry

NCT05199532

Eosinophilic EsophagitisEosinophilic Gastroenteritis+2 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 30, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Prospective Registry of EoSinophilic esOphagitis

Inclusion Criteria

Exclusion Criteria

A U.S. Registry of Eosinophilic Esophagitis Pediatric, Adolescent and Adult Patients Treated With DUPIXENT® As Standard of Care

Eosinophilic Gastrointestinal Disorders Registry

Once Daily Versus Twice Daily Budesonide Orodispersible Tablets for Induction of Remission in EoE

Esophageal String Test Monitoring to Monitor Eosinophilic Esophagitis During Oral Immunotherapy

Dupilumab Versus Topical Corticosteroid Effectiveness - Comparison in the Treatment of Stenotic EoE

Targeted Elimination Diet in EoE Patients Following Identification of Trigger Nutrients Using Confocal Laser Endomicroscopy